News & Views

Signing the Sino-UK partnership with the Chinese PM’s delegation, Foreign & Commonwealth Office, London June 2014. 

HE Ambassador Liu Xiaoming, Chinese Ambassador to London 中国驻伦敦大使刘晓明	HE Sir Sebastian Wood, UK Ambassador to China 英国驻中国大使Sebastian Wood
“Dr Haworth is right to champion the opportunities for Sino-UK collaboration in the field of life sciences. Life sciences is one of the most important areas for collaboration and I congratulate Dynasty Biotechnology on the progress they are making in partnership with Chinese firms and regional government institutions. If our science entrepreneurs can work together, then we will have an extraordinary impact on global healthcare. That is an outcome worthy of our joint commitment.”Haworth博士关于中英在生命科学领域合作机遇的看法很有见地。生命科学是中英最重要的合作领域之一，我祝贺王朝生物技术公司与中国的企业和地方政府机构合作所取得的进展。如果两国科技企业携手合作，将对全球医疗保健行业产生非凡的影响，这值得我们共同努力。	“I was delighted to learn of the successes that Dynasty Biotechnology has delivered in China. UK-China life sciences collaboration has the potential to bring great benefit to both nations and improve the quality of life for millions of people. For this reason I am very happy to see this progress and highlight it as another example of excellent cooperation with our Chinese partners.” 我非常高兴的了解到王朝生物技术公司在中是国取得的成就。英中在生命科学领域的合作能为两国带来巨大的利益并将改善数百万人民的生活质量。因为这个原因我十分高兴的看到所取得的进展，并将此作为我们与中国合作伙伴的另一 个良好合作的榜样。

• “The UK Government recognises the strong potential for collaboration between the UK and China and actively welcomes partnership for innovation. Dynasty Biotechnology enters the market at a time when all recognise the value of our Sino-UK relationship.” 
• “The UK Life Sciences Strategy recognises that we must use our outstanding science base to its fullest potential in order that we remain at the forefront of the new life sciences landscape. Dynasty itself provides access for international partners to some of the best life science technology in the world.”
• “Dynasty Biotechnology provides further evidence of the UK’s position as the global hub for life sciences, attracting global pharma companies to the UK as their European location of choice, and demonstrating the value of UK life sciences innovation in China – one of the world’s most important markets.”

See link for the full UKTI Press release: https://www.gov.uk/government/news/uk-and-china-agree-14-billion-of-trade-and-investment-deals